Anzeige
Mehr »
Login
Sonntag, 29.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Von 0,059 € auf 0,26 €: Die Gold-Aktie, die alle Erwartungen übertrifft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
264 Leser
Artikel bewerten:
(1)

High Cancer Prevalence and Rise in Number of Pharmacies to Boost Growth Rate of Kinase Inhibitors Market: TMR

- Escalating geriatric population and increasing cancer cases around the globe will serve as growth boosters for the kinase inhibitors market during the assessment period of 2019-2027

- The kinase inhibitors market is prognosticated to record a CAGR of ~4 percent across the forecast period of 2019-2027 owing to the numerous growth factors

ALBANY, N.Y., Jan. 26, 2021 /PRNewswire/ -- The growing cancer prevalence across a variety of regions across the world may bring tremendous growth opportunities for the kinase inhibitors market during the tenure of 2019-2027. Cancer is one of the leading causes of death according to the World Health Organization (WHO). The WHO also estimates that cancer accounts for nearly 9.6 mn deaths yearly across the globe. Hence, these statistics highlight the rising need for developing efficient drugs.

Transparency Market Research Logo

Kinase is an enzyme that performs the function of shuffling protein structure by transferring phosphate collected from Adenosine Triphosphate (ATP). They help in regulating a variety of cell activities in cancer. The rising number of clinical trials being conducted to confirm the efficacy and long-term safety of the researchers may further assure good growth opportunities for the kinase inhibitors market across the assessment period of 2019-2027.

Request for Analysis of COVID-19 Impact on Kinase Inhibitors Market - https://www.transparencymarketresearch.com/covid19.php

The TMR (Transparency Market Research) experts, after a detailed and scrutinized analysis on a plethora of factors estimate the global kinase inhibitors market to expand at a CAGR of ~4 percent between 2019 and 2027. The global kinase inhibitors market was valued at ~US$ 4.6 bn in 2018.

The rising awareness about kinase inhibitors across a considerable populace may invite extensive growth opportunities. The growing utilization of kinase inhibitors in cancer therapies may bring immense growth prospects for the kinase inhibitors market. Various drug discovery programs have led to effective kinase inhibitors, thus influencing the growth of the kinase inhibitors market to a great extent.

Request Brochure of Kinase Inhibitors Market Report - https://www.transparencymarketresearch.com/brochure.php

Kinase Inhibitors Market: Transparency Expert Diagnosis

The TMR analysts project the global kinase inhibitors market to observe rapid growth across the forecast period of 2019-2027. The analysts shed light on the development of cell assays by the players in the kinase inhibitors market owing to their efficacy as compared to biochemical assays.

The analysts further advise the players in the kinase inhibitors market to increase research on exploring a combination of therapeutics for preventing resistance of multikinase inhibitors toward RET-driven cancer. The analysts also suggest the players in the kinase inhibitors market to focus on opportunities in Asia Pacific and North America.

Purchase the Kinase Inhibitors Market Report - https://www.transparencymarketresearch.com/checkout.php

Key Findings of the Report

Expanding Influence of Tyrosine Kinase Inhibitors to Increase Growth Rate

The utilization of tyrosine kinase inhibitors for treating a plethora of autoimmune and inflammatory skin diseases may bring expansive growth prospects for the kinase inhibitors market. The players in the kinase inhibitors market are concentrating on developing this inhibitor type due to its growing influence.

Strategic Collaborations with Researchers to Assure Promising Growth

Manufacturers in the kinase inhibitors market are collaborating with researchers to enable a decision-based understanding of kinase biology, cell signaling, and others. Thus, the growing number of research and development activities will accelerate the growth rate of the kinase inhibitors market to a great extent.

Explore 251 pages of superlative research, current market scenario, and extensive geographical projections. Gain insights into the Kinase Inhibitors Market (Type: Non-receptor Tyrosine Kinase Inhibitors, Receptor Tyrosine Kinase Inhibitors, Multikinase Inhibitors, Serine/Threonine Kinase Inhibitors, Protein Kinase C Inhibitors, RHO Kinase Inhibitors, and Others; Application: Oncology, Inflammatory Diseases, and Others; and Distribution Channel: Hospital Pharmacies, Independent Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 at https://www.transparencymarketresearch.com/report-toc/818

Kinase Inhibitors Market: Geographical Landscape

North America's kinase inhibitors market is extrapolated to invite tremendous growth opportunities across the assessment period. The introduction of novel drugs and escalating cases in the U.S. Asia Pacific is also expected to record a high CAGR between 2019 and 2027. The growing demand for cancer therapeutics may influence the growth rate of the kinase inhibitors market considerably.

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Antiviral Combination Therapies Market: https://www.transparencymarketresearch.com/antiviral-combination-drug-therapies-market.html

Respiratory Antiviral Treatment Market: https://www.transparencymarketresearch.com/respiratory-antiviral-treatment-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/kinase-inhibitors.htm
Website: https://www.transparencymarketresearch.com/

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

© 2021 PR Newswire
Nach der Korrektur – 3 Kupferproduzenten für das Comeback

Kupfer wird oft als „das Gold der Energiewende“ bezeichnet, weil es aufgrund seiner hervorragenden elektrischen Leitfähigkeit eine zentrale Rolle in vielen Technologien spielt, die für nachhaltige Energiesysteme entscheidend sind. Experten gehen aufgrund der Angebotsknappheit von einem Superzyklus aus.

Korrektur als Einstiegschance

Nach Höchstständen im Mai korrigierte das rote Metall stark. Die Abwärtsspirale verstärkte sich in den vergangenen Tagen aufgrund schwacher Konjunkturdaten aus den USA und China. Langfristig könnte sich die aktuell laufende Korrektur als exzellente Einstiegsmöglichkeit herausstellen.

3 Kupferaktien mit hohem Potential

Im neuen, kostenlosen Spezialreport stellen wir drei aussichtsreiche Unternehmen vor, die bei einem weiteren Anstieg überproportional profitieren könnten.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.